Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
SMMT:NASDAQ
Summit Therapeutics Inc
$21.26
-3.89%
(-0.86) 1D
$21.26
0.00% (0.00)
After hours
Closed: Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMMT...
Open
$22.02
High
$22.40
Low
$21.25
Mkt. cap
16.50B
Avg. vol.
3.05M
Volume
2.95M
52-wk high
$36.91
52-wk low
$13.83
EPS
-$1.44
Beta
-1.36
Shares outstanding
776.02M
No. of employees
265
News stories
From sources across the web
About Summit Therapeutics Inc
CEORobert Duggan | Maky Zanganeh
Employees265
Founded2003
Headquarters-
SectorBiotechnology
Websitesmmttx.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
51.26M
208.02M
131.10M
147.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.59M
360.42M
103.12M
77.63M
Operating expense
66.85M
568.44M
234.21M
224.92M
Total operating expenses
66.85M
568.44M
234.21M
224.92M
Operating income
-66.85M
-568.44M
-234.21M
-224.92M
Other non operating income
-
-53.00K
-
-
EBT including unusual items
-62.91M
-565.71M
-231.79M
-219.17M
EBT excluding unusual items
-62.91M
-565.71M
-231.79M
-219.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-62.91M
-565.71M
-231.79M
-219.17M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
3.86M
2.98M
2.78M
5.88M
Interest expense
-
-
-
-
Net interest expenses
3.86M
2.98M
2.78M
5.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-66.83M
-568.40M
-234.17M
-224.88M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer